Document and Entity Information (USD $)	9 Months Ended
	Sep. 30, 2014	Nov. 11, 2014	Jun. 28, 2013
Document And Entity Information
Entity Registrant Name	Echo Therapeutics, Inc.
Entity Central Index Key	0001031927
Document Type	10-Q
Document Period End Date	Sep. 30, 2014
Amendment Flag	true
Amendment description	Echo Therapeutics, Inc. (the "Company") is filing this Amendment No. 1 (this "Amendment") to its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2014 (the "Form 10-Q") to make the following changes: Revising disclosure regarding corporate counsel withdrawal in (i) Note 15 to the Consolidated Financial Statements for the Three and Nine Months ended September 30, 2014, (ii) "Part I - Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations - Business - Recent Developments - Corporate Counsel Withdrawals from Engagement", and (iii) "Part I - Item 3. Disclosure Controls and Procedures - Disclosure Controls and Procedures - Corporate Counsel Withdrawals from Engagement"; Revising disclosure in "Part I - Item 2. Management's DIscussion and Analysis of Financial Condition and Results of Operations - Results of Operations - Comparison of the Three Months ended September 30, 2014 and 2013" to add interest income and interest expenses disclosure; Revising disclosure in "Part I - Item 4. Disclosure Controls and Procedures - Internal Control over Financial Reporting"; Revising the caption of "Part II - Item 1. Legal Proceedings" to correct a typographical error.
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$ 24,732,724
Entity Common Stock, Shares Outstanding		12,631,595
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2014